Literature DB >> 21420487

Detection of plasma autoantibodies to brain tissue in young children with and without autism spectrum disorders.

Christy C Rossi1, Judy Van de Water, Sally J Rogers, David G Amaral.   

Abstract

Autism spectrum disorders (ASDs) are characterized by impaired language and social skills, often with restricted interests and stereotyped behaviors. A previous investigation of blood plasma from children with ASDs (mean age=5½ years) demonstrated that 21% of samples contained autoantibodies that reacted intensely with GABAergic Golgi neurons of the cerebellum while no samples from non-sibling, typically developing children showed similar staining (Wills et al., 2009). In order to characterize the clinical features of children positive for these autoantibodies, we analyzed plasma samples from children enrolled in the Autism Phenome Project, a multidisciplinary project aimed at identifying subtypes of ASD. Plasma from male and female children (mean age=3.2 years) was analyzed immunohistochemically for the presence of autoantibodies using histological sections of macaque monkey brain. Immunoreactivity to cerebellar Golgi neurons and other presumed interneurons was observed for some samples but there was no difference in the rate of occurrence of these autoantibodies between children with ASD and their typically developing peers. Staining of neurons, punctate profiles in the molecular layer of the dentate gyrus, and neuronal nuclei were also observed. Taken together, 42% of controls and subjects with ASD demonstrated immunoreactivity to some neural element. Interestingly, children whose plasma reacted to brain tissue had scores on the Child Behavior Checklist (CBCL) that indicated increased behavioral and emotional problems. Children whose plasma was immunoreactive with neuronal cell bodies scored higher on multiple CBCL scales. These studies indicate that additional research into the genesis and prevalence of brain-directed autoantibodies is warranted.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21420487      PMCID: PMC3313674          DOI: 10.1016/j.bbi.2011.02.011

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  31 in total

1.  Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders.

Authors:  A M Connolly; M G Chez; A Pestronk; S T Arnold; S Mehta; R K Deuel
Journal:  J Pediatr       Date:  1999-05       Impact factor: 4.406

2.  Antibrain antibodies in infantile autism.

Authors:  R D Todd; J M Hickok; G M Anderson; D J Cohen
Journal:  Biol Psychiatry       Date:  1988-03-15       Impact factor: 13.382

3.  Circulating autoantibodies to neuronal and glial filament proteins in autism.

Authors:  V K Singh; R Warren; R Averett; M Ghaziuddin
Journal:  Pediatr Neurol       Date:  1997-07       Impact factor: 3.372

4.  The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism.

Authors:  C Lord; S Risi; L Lambrecht; E H Cook; B L Leventhal; P C DiLavore; A Pickles; M Rutter
Journal:  J Autism Dev Disord       Date:  2000-06

5.  Maternal neuronal antibodies associated with autism and a language disorder.

Authors:  Paola Dalton; Robert Deacon; Andy Blamire; Michael Pike; Ian McKinlay; John Stein; Peter Styles; Angela Vincent
Journal:  Ann Neurol       Date:  2003-04       Impact factor: 10.422

6.  Epidemiology of autistic disorder and other pervasive developmental disorders.

Authors:  Eric Fombonne
Journal:  J Clin Psychiatry       Date:  2005       Impact factor: 4.384

7.  Antibrain antibodies in children with autism and their unaffected siblings.

Authors:  Harvey S Singer; Christina M Morris; Phillip N Williams; Dustin Y Yoon; John J Hong; Andrew W Zimmerman
Journal:  J Neuroimmunol       Date:  2006-07-13       Impact factor: 3.478

8.  Autism: maternally derived antibodies specific for fetal brain proteins.

Authors:  Daniel Braunschweig; Paul Ashwood; Paula Krakowiak; Irva Hertz-Picciotto; Robin Hansen; Lisa A Croen; Isaac N Pessah; Judy Van de Water
Journal:  Neurotoxicology       Date:  2007-11-06       Impact factor: 4.294

9.  Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study.

Authors:  Lisa A Croen; Daniel Braunschweig; Lori Haapanen; Cathleen K Yoshida; Bruce Fireman; Judith K Grether; Martin Kharrazi; Robin L Hansen; Paul Ashwood; Judy Van de Water
Journal:  Biol Psychiatry       Date:  2008-06-20       Impact factor: 13.382

10.  Elevated immune response in the brain of autistic patients.

Authors:  Xiaohong Li; Abha Chauhan; Ashfaq M Sheikh; Sangita Patil; Ved Chauhan; Xiu-Min Li; Lina Ji; Ted Brown; Mazhar Malik
Journal:  J Neuroimmunol       Date:  2009-01-20       Impact factor: 3.478

View more
  22 in total

Review 1.  A model for lupus brain disease.

Authors:  Betty Diamond; Bruce T Volpe
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  Brief Report: Antibodies Reacting to Brain Tissue in Basque Spanish Children with Autism Spectrum Disorder and Their Mothers.

Authors:  Christy C Rossi; Joaquin Fuentes; Judy Van de Water; David G Amaral
Journal:  J Autism Dev Disord       Date:  2013-09-11

Review 3.  Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?

Authors:  Theoharis C Theoharides; Irene Tsilioni; Huali Ren
Journal:  Expert Rev Clin Immunol       Date:  2019-04-22       Impact factor: 4.473

Review 4.  Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?

Authors:  Dominika Gładysz; Amanda Krzywdzińska; Kamil K Hozyasz
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

5.  Is 'bench-to-bedside' realistic for autism? An integrative neuroscience approach.

Authors:  Melissa D Bauman; Cynthia M Schumann
Journal:  Neuropsychiatry (London)       Date:  2013-04

Review 6.  Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder.

Authors:  Helen E Vuong; Elaine Y Hsiao
Journal:  Biol Psychiatry       Date:  2016-08-26       Impact factor: 13.382

Review 7.  The Role of the Immune System in Autism Spectrum Disorder.

Authors:  Amory Meltzer; Judy Van de Water
Journal:  Neuropsychopharmacology       Date:  2016-08-18       Impact factor: 7.853

Review 8.  Biomarkers in autism spectrum disorder: the old and the new.

Authors:  Barbara Ruggeri; Ugis Sarkans; Gunter Schumann; Antonio M Persico
Journal:  Psychopharmacology (Berl)       Date:  2013-10-06       Impact factor: 4.530

9.  Autism-specific maternal anti-fetal brain autoantibodies are associated with metabolic conditions.

Authors:  Paula Krakowiak; Cheryl K Walker; Daniel Tancredi; Irva Hertz-Picciotto; Judy Van de Water
Journal:  Autism Res       Date:  2016-06-17       Impact factor: 5.216

Review 10.  Perinatal stress, brain inflammation and risk of autism-review and proposal.

Authors:  Asimenia Angelidou; Shahrzad Asadi; Konstantinos-Dionysios Alysandratos; Anna Karagkouni; Stella Kourembanas; Theoharis C Theoharides
Journal:  BMC Pediatr       Date:  2012-07-02       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.